Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
about
Current management of aneurysmal bone cystsInhibition of receptor activator of nuclear factor kappa-B ligand pathway for the management of aggressive osteosarcoma.Therapeutic Management of a Substantial Pelvic Aneurysmatic Bone Cyst Including the Off-Label Use of Denosumab in a 35-Year-Old Female Patient.Denosumab treatment in aneurysmal bone cyst: Evaluation of nine cases.[New aspects on giant cell tumor of bone].Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
P2860
Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Receptor-Activator of Nuclear ...... Target in Primary Bone Tumors.
@ast
Receptor-Activator of Nuclear ...... Target in Primary Bone Tumors.
@en
type
label
Receptor-Activator of Nuclear ...... Target in Primary Bone Tumors.
@ast
Receptor-Activator of Nuclear ...... Target in Primary Bone Tumors.
@en
prefLabel
Receptor-Activator of Nuclear ...... Target in Primary Bone Tumors.
@ast
Receptor-Activator of Nuclear ...... Target in Primary Bone Tumors.
@en
P2093
P2860
P1433
P1476
Receptor-Activator of Nuclear ...... Target in Primary Bone Tumors.
@en
P2093
Akira Ogose
Hiroshi Hatano
Hiroyuki Kawashima
Naoto Endo
Takashi Ariizumi
Taro Sasaki
Tetsuo Hotta
Tetsuro Yamagishi
P2860
P304
P356
10.1371/JOURNAL.PONE.0154680
P407
P577
2016-05-10T00:00:00Z